← 홈

ADC

32개 · ADC 1032 · Antibody 4683 · CGT 2713 · 다음 갱신 D-8 · 마지막 7월 21일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 32개
ADCCHotBiologicstaleHoffmann-La RochePhase 2

Luteinizing Hormone-Releasing Hormone (LHRH, Luteinizing Hormone-Releasing Hormone, Luteinizing Hormone-Releasing Hormone (LHRH) Agonists)

Ovarian Cancer · Ovarian Cancer

#OvarianCancer#ADC#Phase2#인기#항체약물접합체+2
효능 ORR 31%임상시험 104상태 RECRUITING
ADCABiologicstaleAmgenPhase 3

Pegfilgrastim (Pegfilgrastim)

Cancer; Colon Cancer · Ovarian Cancer

#OvarianCancer#ADC#Phase3#인기#항체약물접합체+4
효능 ORR 56.7%임상시험 93상태 RECRUITING
ADCBiologicstaleHoffmann-La Rochevedotin (ARON-2EV study)Approved

Platinum Based Chemotherapy (Platinum Based Chemotherapy)

Non-Squamous Non-Small Cell Lung Cancer · Ovarian Cancer

#OvarianCancer#ADC#Approved#인기#항체약물접합체+4
효능 ORR 66%임상시험 68상태 RECRUITING
ADCBiologicstaleAstraZenecaPhase 3

Carboplatin/Paclitaxel (Carboplatin/Paclitaxel)

Advanced Ovarian Cancer · Non-small Cell Lung Cancer

#Non-smallCellLungCancer#ADC#Phase3#인기#항체약물접합체+4
효능 ORR 75%임상시험 66상태 RECRUITING
ADCBiologicstaleARCAGYGovitecanPhase 2

GCSF (GCSF)

Ovarian Cancer · Diffuse Large B-cell Lymphoma

#DiffuseLargeB-cellLymphoma#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 20.4%임상시험 62상태 DISCONTINUED
ADCBiologicAbbVievedotin and mirvetuximab so…Phase 2

Lubricating Eye Drops (Lubricating Eye Drops)

Recurrent Ovarian Cancer; Folate Receptor-Alpha Positive · Recurrent Ovarian Cancer

#RecurrentOvarianCancer#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 0.02%임상시험 60상태 RECRUITING
ADCBiologicstaleAbbViePhase 3

MIRV (Mirvetuximab Soravtansine, Mirvetuximab Soravtansine (MIRV))

Epithelial Ovarian Cancer · Epithelial Ovarian Cancer

#EpithelialOvarianCancer#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+1
효능 ORR 100%임상시험 28상태 RECRUITING
ADCBiologicstaleAbbViePhase 3

Mirvetuximab soravtansine (Mirvetuximab soravtansine)

Endometrial Cancer; Endometrial Adenocarcinoma · Ovarian Cancer

#OvarianCancer#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 100%임상시험 27상태 ACTIVE
ADCBiologicstaleAbbViePhase 2

MIRV; IMGN853 (mirvetuximab soravtansine, mirvetuximab soravtansine (MIRV; IMGN853))

Ovarian Cancer; Fallopian Tube · Ovarian Cancer

#OvarianCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 100%임상시험 27상태 RECRUITING
ADCBiologicstaleAstraZenecaPhase 2

AZD5305 (Saruparib, Saruparib (AZD5305))

Ovarian Cancer; Lung Adenocarcinoma · Ovarian Cancer

#OvarianCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 18상태 RECRUITING
ADCBiologicstaleAstraZenecaPhase 2

AZD5305 (AZD5305)

Ovarian Cancer; Breast Cancer · Ovarian Cancer

#OvarianCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 15상태 RECRUITING
ADCBiologicstaleAstraZenecaPhase 2

Camizestrant (Camizestrant)

Ovarian Cancer; Breast Cancer · Ovarian Cancer

#OvarianCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 15.7%임상시험 14상태 RECRUITING
ADCBiologicstaleRemeGen Co., Ltd.Phase 2

disitamab vedotin (Disitamab Vedotin, RC48, RC48 + Carboplatin)

Ovarian Cancer; HER2 · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 11상태 RECRUITING
ADCBiologicstaleGenmabPhase 3

Rina-S (Rina-S)

High Grade Epithelial Ovarian Cancer; High Grade Serous Ovarian Cancer · Platinum-resistant Ovarian Cancer

#Platinum-resistantOvarianCancer#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+3
임상시험 8상태 RECRUITING
ADCBiologicstaleMerck Sharp & Dohme LLCPhase 2

Raludotatug deruxtecan (Raludotatug deruxtecan)

Ovarian Cancer Recurrent · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 7상태 RECRUITING
ADCBiologicstaleAbbViePhase 3

Mirvetuximab soravtansine plus Bevacizumab (Mirvetuximab soravtansine plus Bevacizumab)

Ovarian Cancer; Peritoneal Cancer · Ovarian Cancer

#OvarianCancer#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 100%임상시험 6상태 RECRUITING
ADCBiologicstaleTasly Pharmaceutical Group Co.,…Phase 2

STRO-002 (STRO-002)

Neoplasm Malignant · Ovarian Cancer

#OvarianCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 6상태 DISCONTINUED
ADCBiologicstaleAstraZenecaPhase 2

AZD9574 (AZD9574)

Advanced Solid Malignancies · Ovarian Cancer

#OvarianCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 5상태 RECRUITING
ADCBiologicstaleAstraZenecaPhase 3

AZD5335 (AZD5335)

Epithelial Ovarian Cancer · Ovarian Cancer

#OvarianCancer#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+2
임상시험 3상태 RECRUITING
ADCBiologicstaleTORL Biotherapeutics, LLCPhase 1

TORL-1-23 (TORL-1-23)

Advanced Solid Tumor; Ovarian Cancer · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 3상태 RECRUITING

1 / 2 페이지

← 이전다음 →